Table 5 Basic characteristics of study collective.

From: Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to 68Ga-PSMA PET-CT

 

mean

SD

median

range

Age (years)

72.1

7.5

73

51–89

Days 68GA-PSMA-PET to MRI

72.7

48.4

63

0–180

Days PSA to 68GA-PSMA-PET

26.5

43

0

0–193

PSA (ng/ml)

15.8

23.6

9.7

0.2–196

T-Stage

2.5

0.7

2.5

1–4

Prostate volume (ml)

68.8

36.0

68

10–188

Gleason score biopsy

7, 9

1.0

8

6–10

Gleason score after surgery

7.7

0.9

7

7–9

  1. The basic characteristics of the prostate cancer patients who received a 68Gallium-Prostate specific membrane antigen (68Ga-PSMA) PET-CT and a multiparametric MRI within 180 days investigated in this study are presented in this table. This included the age of the patients, the delay between both imaging modalities, the prostate specific antigen blood level, the delay towards the 68Ga-PSMA PET-CT, prostate volumes, the Gleason scores from biopsy and after surgery and the tumor stages. Data are given in means, standard deviations, medians and ranges.
  2. Abbreviations: PSMA = Prostate specific membrane antigen, PET = Positron emission tomography, MRI = Magnetic resonance imaging, PSA = Prostate specific antigen blood level.
Back to article page